Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 916542 Boston, MA
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,007,215
+$6,342,306 QoQ
Shares Held
2,681,900
-5.8% QoQ
Ownership
3.74%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 114 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. ZNTL ranks #12 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in ZNTL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,007,215 2,681,900
2026-03-31 $6,664,909 2,848,252
2025-12-31 $3,846,546 2,849,294
2025-09-30 $4,296,179 2,845,152
2025-06-30 $3,246,863 2,799,020
2025-03-31 $4,251,715 2,674,035
2024-12-31 $3,233,715 1,067,233
2024-09-30 $968,634 263,216